A Study of BMS-986195 in Healthy Male Subjects
NCT03245515 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2018-01-05
Summary
The purpose of this study is to investigate the effects BMS-986195 in healthy male subjects.
Conditions
Interventions
- DRUG
-
BMS-986195
specified dose on specified days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-15
- Primary Completion
- 2017-09-22
- Completion
- 2017-10-05
- FDA Drug
- Yes
Countries
- Netherlands
Study Locations
More Related Trials
-
PoC in Rheumatoid Arthritis With Methotrexate
NCT00605735 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis
NCT02534896 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis
NCT02638948 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
NCT00482417 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects
NCT07200596 ·Status: RECRUITING ·Phase: PHASE1
-
Study Evaluating TMI-005 in Active Rheumatoid Arthritis
NCT00095342 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
NCT01373151 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
NCT00959036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis
NCT02504671 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
NCT06883695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00420199 ·Status: COMPLETED ·Phase: PHASE3
-
INCB047986 in Rheumatoid Arthritis
NCT02151474 ·Status: TERMINATED ·Phase: PHASE2
-
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
NCT00122382 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
NCT00345748 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
NCT00838565 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background
NCT00162292 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis
NCT02531178 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants
NCT01442545 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
NCT02865434 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess CH1504 in Patients With Active Rheumatoid Arthritis
NCT00658047 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate
NCT00620685 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants
NCT06115967 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
NCT00048932 ·Status: COMPLETED ·Phase: PHASE3